[1]Brown SE, Tong W, Krebsbach PH. The derivation of mesenchymal stem cells from human embryonic stem cells[J]. Cells Tissues Organs,2009, 189(1-4):256-260.
[2]Frohman EM, Racke MK, Raine CS. Multiple sclerosis-the plaque and its pathogenesis[J].N Engl J Med,2006, 354(9): 942-955.
[3]Kassis I, Petrou P, Halimi M, et al. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors[J]. Immunol Lett, 2013, 154(1-2): 70-76.
[4]Chong WP, Horai R, Mattapallil MJ, et al.IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses[J].J Autoimmun,2014,50:12-22.
[5]Fan Y, Rudert WA, Grupillo M, et al. Thymus-specific deletion of insulin induces autoimmune diabetes [J]. EMBO J,2009,28(18): 2812-2824.
[6]Keegan BM, Noseworthy JH. Multiple sclerosis[J]. Ann Rev Med, 2002, 53: 285-302.
[7]Siepe M, Thomsen AR, Duerkopp N, et al. Human neonatal thymus-derived mesenchymal stromal cells: characterization,differentiation, and immunomodulatory properties[J]. Tissue Eng Part A,2009,Part A 15(7): 1787-1796.
[8]Zhang Q, Shi S, Liu Y, et al. Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis[J].J Immunol,2009,183(12):7787-7798.
[9]Erices AA, Allers CI, Conget PA, et al. Human cord blood-derived mesenchymalstem cells home and survive in the marrow of immunodeficient mice after systemic infusion [J].Cell Transplant,2003,12(6):555-561.
[10]Barry FP,Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization[J].Int J Biochem Cell Biol,2004,36(4) : 568 -584.
[11]Kassis I, Grigoriadis N, Gowda-Kurkalli B, et al. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis[J]. Arch Neurol,2008,65(6):753-761.
[12]Hocking AM,Gibran NS. Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair[J]. Exp Cell Res,2010,316 (14) : 2213-2219.
[13]Liu L,Yu Y,Hou Y,et al. Human umbilical cord mesenchymal stem cells transplantation promotes cutaneous wound healing of severe burned rats[J]. PLoS One,2014,9(2) :e88348.
[14]Kestendjieva S,Kyurkchiev D,Tsvetkova G,et al.Characterization of mesenchymal stem cells isolated from the human umbilical cord[J].Cell Biol Int,2008,32(7) : 724-732.
[15]Auletta JJ,Bartholomew AM,Maziarz RT,et al. The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis[J]. Immunotherapy, 2012,4(5), 529-547.
[16]Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: nature, biology and potential application[J]. Stem Cells, 2001, 19(3):180-192.
[17]Constantin G, Marconi S, Rossi B, et al. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis[J].Stem Cells,2009,27(10):2624-2635.
[18]Jadidi-Niaragh F, Mirshafiey A.Th17 cell, the newplayer of neuroinflammatory process in multiple sclerosis[J]. Scand J Immunol, 2011,74 (1):1-13.
[19]Luz-Crawford P, Kurte M, Bravo-Alegria J, et al. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells[J]. Stem Cell Res Ther, 2013,4(3):65.
[20]Matysiak M, Orlowski W, Fortak-Michalska M, et al. Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2[J]. J Neuroimmunol, 2011,233(1-2):106-111.
[21]Gao F, Chiu SM, Motan DA,et al. Mesenchymal stem cells and immunomodulation:current status and future prospects[J]. Cell Death Dis, 2016, 7:e2062.
[22]Rafei M, Campeau PM, Aguilar-Mahecha A, et al. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner[J].J Immunol, 2009,182(10):5994-6002.
[23]Wang XF, Kimbrel EA, Ijichi K, et al. Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis[J]. Stem Cell Reports, 2014, 3(1): 115-130.
|